{{Rsnum
|rsid=9512730
|Chromosome=13
|position=27503007
|Orientation=plus
|GMAF=0.2199
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 3.1 | 45.3 | 51.6
| HCB | 0.0 | 15.6 | 84.4
| JPT | 0.0 | 6.7 | 93.3
| YRI | 4.8 | 35.5 | 59.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 15.6 | 84.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs9512730
|PubMedID=18347602
|Condition=Schizophrenia
|Gene=Intergenic
|Risk Allele=
|pValue=5.00E-006
|OR=1.52
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs9512730
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18347602; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genomewide association for schizophrenia in the CATIE study: results of stage 1 (Initial Sample Size: 738 cases, 733 controls; Replication Sample Size: NR). This variant is associated with Schizophrenia.
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356465
}}

{{PMID Auto
|PMID=20823317
|Title=is-rSNP: a novel technique for in silico regulatory SNP detection.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9512730
|overall_frequency_n=21
|overall_frequency_d=128
|overall_frequency=0.164062
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=21
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}